News

Gen Z grads are slamming degrees as worthless—but Fortune 500 boss, Doina Ionescu, says her MBA was the best investment ...
Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to ...
The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating ...
Merck & Co., Inc. (NYSE:MRK) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald ...
The Dow Jones Industrial Average is down Tuesday afternoon with shares of Nike and Merck facing the biggest losses for the blue-chip average.
Dragged down by declines for shares of Nike and Merck, the Dow Jones Industrial Average is falling Tuesday afternoon.
The Israel-Iran clash seemingly has no end in sight — a prospect that does not seem to be panicking the markets.
In this video, Susana M. Campos, MD, MPH, discusses results from a phase 2 trial of pembrolizumab and lenvatinib for patients with recurrent or persistent clear-cell ovarian cancer.Findings from the ...
During a live event, Chandler H. Park, MD, and participants discuss NCCN guidelines and TiNivo-2 data for second-line renal ...
The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...
The pending deal was rumored overnight after a report from the Financial Times, spurring analysts to speculate that if true, ...
Company scales leadership to accelerate growth and reinforce market position as the leader in AI-powered life sciences ...